Friday, October 2, 2020, 8:00 AM - 4:00 PM, Virtual Conference, Philadelphia, PA

This one-day course is designed to present the latest developments in research and clinical care for very-early-onset inflammatory bowel disease (VEO-IBD) and pediatric IBD. Participants will receive a comprehensive overview of the genomic, immunologic and microbiome discoveries in VEO-IBD and in pediatric IBD, and of advances in the diagnosis, medical and surgical management of the disease. This will include lectures by nationally and internationally recognized experts, interactive panel discussions and case presentations from the audience.

1. Learn about the genetics of VEO-IBD, new candidate genes and the relevance of these discoveries to disease development
2. Describe the role of the dysregulated immune system in VEO-IBD and pediatric IBD and how this can impact therapeutic strategies
3. Review the management of difficult cases in VEO-IBD and pediatric IBD
4. Determine appropriate therapy for patients with VEO-IBD and pediatric IBD, considering both the patient’s phenotype and underlying genetics
5. Review the potential infectious complications that can be seen in patients with VEO-IBD and pediatric IBD
6. Determine the therapeutic targets in pediatric IBD and outcome measures of success of therapy
7. Discuss the management of difficult cases in VEO-IBD and pediatric IBD
8. Discuss the role of surgery in pediatric IBD: how to determine optimal timing for intervention
9. Explain how to counsel patients about the role of diet in disease development and as therapy for patients with IBD

The Children's Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians.

AMA PRA Category 1 Credits™ (5.25 hours), Non-Physician Attendance (includes PA, RN, BSN, ARNP) (5.25 hours)

The registration form for this activity is currently unavailable.

Friday, October 2, 2020